Reducing high intraocular pressure with strong sodiumchloride infusion before eyesurgery

Reducing high intraocular pressure with hypertonic saline infusion before eyesurgery

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-005025-70-FI

Enrollment

Registered

2012-11-27

Start date

2012-12-21

Completion date

Unknown

Last updated

2013-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated eyepressure MedDRA version: 14.1 Level: LLT Classification code 10022805 Term: Intraocular pressure high System Organ Class: 100000004848

Interventions

Trade Name: Natriumklorid Braun 234 mg/ml inf Product Name: Natriumklorid Braun 234 mg/ml inf Pharmaceutical Form: Infusion Other descriptive name: SODIUM CHLORIDE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Intraocular pressure 30 mmHg or more before cataract or glaukoma surgery, age 25-80 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 23 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 23

Exclusion criteria

Exclusion criteria: Ödemin medication, age under 25 or age more than 80, kidney failure, heart failure, dementia, other medical disorder that affects significantly patients condition

Design outcomes

Primary

Measure	Time frame
Main Objective: Change in ocular pressure;Secondary Objective: Blood pressure, pulse;Primary end point(s): Eyepressure after NaCl bolus or mannitol infusion;Timepoint(s) of evaluation of this end point: 30 minutes	—

Secondary

Measure	Time frame
Secondary end point(s): Eyepressure after NaCl bolus or mannitol infusion;Timepoint(s) of evaluation of this end point: 5, 10 and 20 minutes	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026